NCT02123134View on ClinicalTrials.gov

Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Moderate to Severe Convexity of Submental FatSafetyEfficacy
Interventions
DRUG

ATX-101

Formulated as an injectable solution containing deoxycholic acid at a concentration of 10 mg/mL.

DRUG

Placebo

Phosphate buffered saline placebo for injection

Trial Locations (6)

10604

White Plains

34209

Bradenton

35205

Birmingham

45255

Cincinnati

70006

Metairie

90036

Los Angeles

Sponsors
All Listed Sponsors
lead

Kythera Biopharmaceuticals

INDUSTRY